Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Flapan

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Science (London, England : 1979)|September 16, 2004
Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementationStanley Chia, Robert Wilson, Christopher A Ludlam, et al.
BMJ Open|September 28, 2013
Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trialJehangir N Din, Jaydeep Sarma, Scott A Harding, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2002
Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimusGeorge Therapondos, Andrew D Flapan, Matthias M Dollinger, et al.
Heart (British Cardiac Society)|November 28, 2012
Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokersJehangir N Din, Rachel M Archer, Scott A Harding, et al.
Atherosclerosis|June 20, 2007
Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in manJehangir N Din, Scott A Harding, Christopher J Valerio, et al.
Circulation. Cardiovascular Interventions|May 6, 2010
Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgeryNicholas L M Cruden, Scott A Harding, Andrew D Flapan, et al.
American Heart Journal|June 25, 2004
Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled studyGraham S Hillis, Claire V Pearson, Scott A Harding, et al.
Circulation. Cardiovascular Interventions|July 8, 2010
Percutaneous coronary intervention in the elderly: changes in case-mix and periprocedural outcomes in 31,758 patients treated between 2000 and 2007Cathy Johnman, Keith G Oldroyd, Danny F Mackay, et al.
European Heart Journal|August 19, 2009
Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary interventionClaire E Hastie, Sandosh Padmanabhan, Rachel Slack, et al.
Journal of Public Health (Oxford, England)|March 4, 2008
Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in ScotlandDavid Austin, Keith G Oldroyd, Alex McConnachie, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Science (London, England : 1979)|September 16, 2004
Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementationStanley Chia, Robert Wilson, Christopher A Ludlam, et al.
BMJ Open|September 28, 2013
Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trialJehangir N Din, Jaydeep Sarma, Scott A Harding, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2002
Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimusGeorge Therapondos, Andrew D Flapan, Matthias M Dollinger, et al.
Heart (British Cardiac Society)|November 28, 2012
Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokersJehangir N Din, Rachel M Archer, Scott A Harding, et al.
Atherosclerosis|June 20, 2007
Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in manJehangir N Din, Scott A Harding, Christopher J Valerio, et al.
Circulation. Cardiovascular Interventions|May 6, 2010
Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgeryNicholas L M Cruden, Scott A Harding, Andrew D Flapan, et al.
American Heart Journal|June 25, 2004
Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled studyGraham S Hillis, Claire V Pearson, Scott A Harding, et al.
Circulation. Cardiovascular Interventions|July 8, 2010
Percutaneous coronary intervention in the elderly: changes in case-mix and periprocedural outcomes in 31,758 patients treated between 2000 and 2007Cathy Johnman, Keith G Oldroyd, Danny F Mackay, et al.
European Heart Journal|August 19, 2009
Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary interventionClaire E Hastie, Sandosh Padmanabhan, Rachel Slack, et al.
Journal of Public Health (Oxford, England)|March 4, 2008
Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in ScotlandDavid Austin, Keith G Oldroyd, Alex McConnachie, et al.
Pageof 3